-
Altimmune (NASDAQ:ALT) Earns Buy Rating from Analysts at Stifel Nicolaus
Source: Buzz FX / 08 Jan 2025 08:26:15 America/New_York
Altimmune (NASDAQ:ALT) Earns Buy Rating from Analysts at Stifel Nicolaus Written by MarketBeat January 8, 2025 Share Link copied to clipboard. Stock analysts at Stifel Nicolaus assumed coverage on shares of Altimmune ( NASDAQ:ALT - Get Free
Read more...